Immune checkpoint inhibitors for patients with microsatellite instability-high colorectal cancer: protocol of a pooled analysis of clinical trials

首页 > 成果 > 详情

认领

导出

Link by DOI

反馈

作者信息关键词期刊信息基础信息归属信息摘要

成果类型：

期刊论文

作者：

Tang, Xiaojun;Xu, Xinshu;Chen, Ruobing;Zhang, Mengmeng;Mei, Zubing;...

通讯作者：

Zhang, SX;Mei, ZB

作者机构：

[Tang, Xiaojun] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Spinal Surg, Hengyang, Hunan, Peoples R China.

[Xu, Xinshu; Chen, Ruobing; Zhang, Shuangxi; Zhang, Mengmeng] Henan Univ Chinese Med, Dept Anorectal Surg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.

[Xu, Xinshu; Chen, Ruobing; Zhang, Mengmeng] Henan Univ Chinese Med, Clin Med Coll 1, Zhengzhou, Henan, Peoples R China.

[Mei, Zubing; Mei, ZB] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Anorectal Surg, Shanghai, Peoples R China.

[Mei, Zubing; Mei, ZB] Shuguang Hosp, Anorectal Dis Inst, Shanghai, Peoples R China.

通讯机构：

[Zhang, SX ] H

[Mei, ZB ] S

Henan Univ Chinese Med, Dept Anorectal Surg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.

Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Anorectal Surg, Shanghai, Peoples R China.

Shuguang Hosp, Anorectal Dis Inst, Shanghai, Peoples R China.

语种：

英文

关键词：

clinical trials;colorectal cancer;immune checkpoint inhibitors;microsatellite instability-high;pooled analysis

期刊：

FRONTIERS IN ONCOLOGY

ISSN：

2234-943X

年：

2024

卷：

页码：

1331937

DOI：

10.3389/fonc.2023.1331937

基金类别：

Key Research and Promotion Project of Henan Province (Science and Technology Tackling Project) [232102311221]; Hunan Provincial Natural Science Foundation of China [2022JJ30519]; Scientific Research Fund of Hunan Provincial Health Commission [20200968]; Scientific Research Fund of Hengyang Science and Technology Bureau [2019jh010988]

机构署名：

本校为第一机构

摘要：

INTRODUCTION: Colorectal cancer (CRC) is the third most common cause of cancer and the second leading cause of cancer-related deaths worldwide. Microsatellite instability-high (MSI-H) is a distinct molecular subtype of CRC that occurs in approximately 15% of all cases. Recently, immune checkpoint inhibitors (ICIs) have emerged as a promising therapeutic approach for patients with MSI-H colorectal cancer, exhibiting higher response rates than standard chemotherapies. To assess the effectiveness and safety of ICIs for the treatment of patients wi...

反馈

产权有误：本人成果被他人认领

数据有误：数据基本信息有误

归属有误：成果的院系归属、机构署名归属有误

其他原因：

验证码：

看不清楚，换一个

确定

取消

成果认领

标题：

用户	作者	通讯作者	--
	请选择	请选择	--

确定

取消

Immune checkpoint inhibitors for patients with microsatellite instability-high colorectal cancer: protocol of a pooled analysis of clinical trials

反馈

成果认领

提示

该栏目需要登录且有访问权限才可以访问